SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001664710-21-000020
Filing Date
2021-03-25
Accepted
2021-03-25 08:31:00
Documents
29
Period of Report
2021-03-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K keros-form8xkcorporatedeck.htm 8-K 31238
2 EX-99.1 kerostherapeutics-corpor.htm EX-99.1 29090
3 GRAPHIC kerostherapeutics-corpor001.jpg GRAPHIC 104908
4 GRAPHIC kerostherapeutics-corpor002.jpg GRAPHIC 248133
5 GRAPHIC kerostherapeutics-corpor003.jpg GRAPHIC 190309
6 GRAPHIC kerostherapeutics-corpor004.jpg GRAPHIC 116955
7 GRAPHIC kerostherapeutics-corpor005.jpg GRAPHIC 101798
8 GRAPHIC kerostherapeutics-corpor006.jpg GRAPHIC 144482
9 GRAPHIC kerostherapeutics-corpor007.jpg GRAPHIC 143830
10 GRAPHIC kerostherapeutics-corpor008.jpg GRAPHIC 132585
11 GRAPHIC kerostherapeutics-corpor009.jpg GRAPHIC 138345
12 GRAPHIC kerostherapeutics-corpor010.jpg GRAPHIC 145155
13 GRAPHIC kerostherapeutics-corpor011.jpg GRAPHIC 106023
14 GRAPHIC kerostherapeutics-corpor012.jpg GRAPHIC 118462
15 GRAPHIC kerostherapeutics-corpor013.jpg GRAPHIC 103377
16 GRAPHIC kerostherapeutics-corpor014.jpg GRAPHIC 143961
17 GRAPHIC kerostherapeutics-corpor015.jpg GRAPHIC 99774
18 GRAPHIC kerostherapeutics-corpor016.jpg GRAPHIC 117041
19 GRAPHIC kerostherapeutics-corpor017.jpg GRAPHIC 140762
20 GRAPHIC kerostherapeutics-corpor018.jpg GRAPHIC 134868
21 GRAPHIC kerostherapeutics-corpor019.jpg GRAPHIC 215008
22 GRAPHIC kerostherapeutics-corpor020.jpg GRAPHIC 111070
23 GRAPHIC kerostherapeutics-corpor021.jpg GRAPHIC 145830
24 GRAPHIC kerostherapeutics-corpor022.jpg GRAPHIC 104668
25 GRAPHIC kerostherapeutics-corpor023.jpg GRAPHIC 152558
26 GRAPHIC kerostherapeutics-corpor024.jpg GRAPHIC 86443
27 GRAPHIC kerostherapeutics-corpor025.jpg GRAPHIC 164834
28 GRAPHIC kerostherapeutics-corpor026.jpg GRAPHIC 96549
29 GRAPHIC kerostherapeutics-corpor027.jpg GRAPHIC 83641
  Complete submission text file 0001664710-21-000020.txt   5011298
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39264 | Film No.: 21770177
SIC: 2834 Pharmaceutical Preparations